Press release
Erythropoietin Stimulating Agents Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Erythropoietin Stimulating Agents Market
Global erythropoietin stimulating agents market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.
Market Outline: Global Erythropoietin Stimulating Agents Market
Erythropoietin is a hormone produced by kidney that enables stimulate production of RBC. Erythropoietin stimulating agents are the drugs used to stimulate the bone marrow to enhance the production of red blood cells. The drugs are commonly used in the treatment of anemia due to end stage renal disease (ESRD), major surgeries, chemotherapy, and HIV/AIDS leads to decrease the need of blood transfusion.
Market Dynamics: Global Erythropoietin Stimulating Agents Market
Rise in prevalence of anemia, ESRD, HIV, and cancer around the globe is witnessed to increased demand for global erythropoietin stimulating agents market. Moreover, rise in R&D for innovation of newer drugs, entry of bio-similar and generics into market due to expiration of patents are expected to increase in the adoption of low-cost drugs in developing countries, and rise in awareness about the benefits erythropoietin drugs are anticipated to propel the erythropoietin stimulating agents market over the forecast period. However, stringent regulations for the product approval, adverse effects associated with drugs, and high cost of patented drugs are impede the growth of erythropoietin stimulating agents market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Global Erythropoietin Stimulating Agents Market
Erythropoietin stimulating agents market is segmented on the basis of product type, application and distribution channel
Based on the product type, the market is segmented into the following:
• Epoetin-Alfa
• Epoetin-Beta
• Epoetin-Delta
• Epoetin-Omega
• Darbepoetin-Alfa
• Others
Based on the route of application, the market is segmented into the following:
• Oncology
• Renal Disorders
• Anemia
• Surgeries
• Others
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Global Erythropoietin Stimulating Agents Market
Geographically, global erythropoietin stimulating agents market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America erythropoietin stimulating agents market is expected to dominate the revenue share due to increase in the prevalence of anemia, rise in number of major surgical procedures, and development of biosimilar by market players are expected to fuel the market. Europe erythropoietin stimulating agents market is driven by increase in the incidence of cancers in UK, Germany, and France, rise in awareness about the erythropoietin drugs, increase in the R&D investment for the development of newer drugs are expected to surge the market. However, Asia Pacific erythropoietin stimulating agents market is witnessed enormous growth opportunities due to increase in the medical tourism in Asia Pacific countries, adoption of newer drugs, and launch of generic drugs into Asia Pacific market are expected to drive the market.
Competition Assessment: Global Erythropoietin Stimulating Agents Market
Some of the players in the global erythropoietin stimulating agents market include:
• Teva Pharmaceutical Industries Ltd. (Israel)
• Biocon Limited (India)
• Celltrion, Inc. (South Korea)
• Hoffmann La Roche, Ltd. (Switzerland)
• Hospira, Inc. (Pfizer, Inc.) (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Amgen, Inc. (U.S.)
• Dr. Reddy’s Laboratories Ltd (India)
• Intas Pharmaceuticals (India)
• 3SBio, Inc. (China)
• Kissei Pharmaceuticals Ltd (Japan)
Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market/#ulp-14mlyhjMGhVjZqa3
Notable Market Developments: Erythropoietin Stimulating Agents Market
• In January 2018, Kissei Pharmaceutical Company and JCR Pharmaceuticals announced positive results of Phase 3 study for JR-131, a biosimilar for darbopoetin alfs.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/erythropoietin-stimulating-agents-market
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Stimulating Agents Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 here
News-ID: 1077789 • Views: …
More Releases from Precision Business Insights
Gaming Controller Market Rising Demand for Gaming Stations and eSports
According to the Precision Business Insights (PBI), latest report the gaming controller market size was valued at USD 2,382.1 million in 2023, growing at an 8.5% CAGR from 2024 to 2030. The key drivers of the expansion of the global gaming controller include the enhanced gaming experience, technology advancements, consumer preferences and ergonomics, competitive gaming and esports, intuitiveness, and portability of the gaming controllers.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/gaming-controller-market …
Next Generation Dietary Supplements Market Size, Growth Opportunities 2024-2030
According to Precision Business Insights (PBI), the latest report, the global next-generation dietary supplements market was valued at USD 10,752.3 million in 2023 and is expected to grow at a CAGR of 8.8% from 2024-2030. The primary factors that drive the market are the growing demand for rising consumer knowledge of the various health benefits of Next Generation Dietary Supplements, as well as rising disposable income levels, fuel market expansion…
Catamaran Market Increasing Popularity Of Water Sports And Fishing Activities
According to Precision Business Insights (PBI), the latest report, the catamaran market is valued at USD 1,635.7 million in 2023 and is anticipated to grow a CAGR of 4.9% over the forecast period. The primary factors that drive the market are the growing demand for Catamaran pushes the market to enhance efficiency, minimize time consumption, and reduce post-harvest operating losses. Catamaran are good solutions for reducing high labour costs since…
Refrigerated Display Cases Market Size, Share, Growth Trends and Forecast 2024-2 …
According to Precision Business Insights (PBI), latest report, the refrigerated display cases market was valued at USD 8,248.5 million in 2023 and is expected to grow at a 5.1% CAGR from 2024 to 2030. The primary drivers of the expansion of the global refrigerated display cases market include the increasing demand for frozen food and drinks among urban consumers. In addition, growing awareness about environment sustainability and energy efficiency is…
More Releases for Erythropoietin
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Erythropoietin Drugs Market Size, Opportunities 2022-2030
The Erythropoietin Drugs Market. The report delves into current trends, growth drivers, competitive landscape, and future forecasts, providing invaluable insights for stakeholders looking to understand the dynamics of this rapidly evolving sector. The global erythropoietin drugs market is poised for substantial growth, and the insights provided in this report are crucial for navigating this promising landscape.
-------------------------------------------------------------------------------------------------------------------
REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2675
-------------------------------------------------------------------------------------------------------------------
Market Overview:
The global erythropoietin drugs market was…
Erythropoietin Drugs Market - Revitalizing Lives: Erythropoietin Drugs for Enhan …
Newark, New Castle, USA: The "Erythropoietin Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Erythropoietin Drugs Market: https://www.growthplusreports.com/report/erythropoietin-drugs-market/8627
This latest report researches the industry structure, sales, revenue,…
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view the…
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of…
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development of…
